- Report
- May 2024
- 140 Pages
Global
From €5837EUR$6,499USD£4,999GBP
- Report
- May 2024
- 136 Pages
Global
From €5837EUR$6,499USD£4,999GBP
- Report
- May 2024
- 140 Pages
Global
From €5837EUR$6,499USD£4,999GBP
- Report
- July 2023
- 118 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- August 2022
- 120 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- August 2022
- 120 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- August 2022
- 119 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- July 2022
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- January 2024
- 200 Pages
Global
From €3727EUR$4,150USD£3,192GBP
- Report
- May 2023
- 160 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- May 2023
- 140 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- April 2023
- 147 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- April 2023
- 147 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- April 2023
- 147 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- March 2024
- 180 Pages
Global
From €7140EUR$7,950USD£6,115GBP
- Report
- March 2024
- 120 Pages
Global
From €7140EUR$7,950USD£6,115GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4445EUR$4,950USD£3,807GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4445EUR$4,950USD£3,807GBP
- Report
- November 2023
- 30 Pages
Global
From €2470EUR$2,750USD£2,115GBP
- Report
- November 2023
- 30 Pages
Global
From €2470EUR$2,750USD£2,115GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more